Association for Research in Vision and Ophthalmology

Association for Research in Vision and Ophthalmology

May 16, 2017
1 min watch
Save

VIDEO: Real-world Xen glaucoma implant technique improves on FDA-approved technique

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Davinder S. Grover, MD, MPH, discusses an FDA-approved, prospective, open-label study of the Allergan Xen implant for the treatment of refractory glaucoma. The study looks at a less-invasive "real-world" ab interno technique than the one approved in the FDA clinical trial.